Stryker to Acquire French Joint Replacement Company SERF SAS

Stryker (San Jose, CA, USA), one of the world's leading medical technology companies, has executed a binding offer to acquire SERF SAS (Décines-Charpieu, France), a joint replacement company.

SERF SAS, which has a legacy of over 50 years, is recognized by healthcare professionals across the world for its innovations in hip implants, such as the invention of the original Dual Mobility Cup. The acquisition of SERF SAS is expected to further strengthen Stryker's existing presence in France and across Europe, as well as expand its global joint replacement portfolio, enabling the company to cater to a wider range of patients. The proposed acquisition is likely to close in the first quarter of 2024, subject to customary closing conditions, including regulatory approvals.

Related Links:
Stryker 
SERF SAS 

Visit expo >

Gold Member

SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test

SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Gold Member

STI Test

Vivalytic Sexually Transmitted Infection (STI) Array

Silver Member

Compact 14-Day Uninterrupted Holter ECG

NR-314P

New

Crossover Incubator

CR60002